Journey Medical Statistics
Total Valuation
Journey Medical has a market cap or net worth of $157.80 million. The enterprise value is $163.20 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, after market close.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Journey Medical has 23.10 million shares outstanding. The number of shares has increased by 12.06% in one year.
| Current Share Class | 17.10M |
| Shares Outstanding | 23.10M |
| Shares Change (YoY) | +12.06% |
| Shares Change (QoQ) | +3.77% |
| Owned by Insiders (%) | 12.58% |
| Owned by Institutions (%) | 17.45% |
| Float | 10.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.49 |
| Forward PS | 2.05 |
| PB Ratio | 7.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 1.28.
| Current Ratio | 1.37 |
| Quick Ratio | 0.87 |
| Debt / Equity | 1.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.07 |
Financial Efficiency
Return on equity (ROE) is -72.60% and return on invested capital (ROIC) is -20.39%.
| Return on Equity (ROE) | -72.60% |
| Return on Assets (ROA) | -10.88% |
| Return on Invested Capital (ROIC) | -20.39% |
| Return on Capital Employed (ROCE) | -30.35% |
| Revenue Per Employee | $1.37M |
| Profits Per Employee | -$357,854 |
| Employee Count | 41 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 1.69 |
Taxes
In the past 12 months, Journey Medical has paid $61,000 in taxes.
| Income Tax | 61,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +94.59% in the last 52 weeks. The beta is 0.87, so Journey Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +94.59% |
| 50-Day Moving Average | 6.25 |
| 200-Day Moving Average | 5.38 |
| Relative Strength Index (RSI) | 51.82 |
| Average Volume (20 Days) | 78,145 |
Short Selling Information
The latest short interest is 332,392, so 1.44% of the outstanding shares have been sold short.
| Short Interest | 332,392 |
| Short Previous Month | 252,109 |
| Short % of Shares Out | 1.44% |
| Short % of Float | 3.07% |
| Short Ratio (days to cover) | 3.18 |
Income Statement
In the last 12 months, Journey Medical had revenue of $56.13 million and -$14.67 million in losses. Loss per share was -$0.72.
| Revenue | 56.13M |
| Gross Profit | 35.26M |
| Operating Income | -13.68M |
| Pretax Income | -3.94M |
| Net Income | -14.67M |
| EBITDA | -10.25M |
| EBIT | -13.68M |
| Loss Per Share | -$0.72 |
Full Income StatementBalance Sheet
The company has $20.31 million in cash and $25.71 million in debt, giving a net cash position of -$5.40 million or -$0.23 per share.
| Cash & Cash Equivalents | 20.31M |
| Total Debt | 25.71M |
| Net Cash | -5.40M |
| Net Cash Per Share | -$0.23 |
| Equity (Book Value) | 20.07M |
| Book Value Per Share | 0.91 |
| Working Capital | 13.00M |
Full Balance SheetCash Flow
| Operating Cash Flow | -9.13M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.13M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
Gross margin is 62.81%, with operating and profit margins of -24.36% and -26.14%.
| Gross Margin | 62.81% |
| Operating Margin | -24.36% |
| Pretax Margin | -26.03% |
| Profit Margin | -26.14% |
| EBITDA Margin | -18.27% |
| EBIT Margin | -24.36% |
| FCF Margin | n/a |
Dividends & Yields
Journey Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.06% |
| Shareholder Yield | -12.06% |
| Earnings Yield | -9.30% |
| FCF Yield | -5.78% |
Analyst Forecast
The average price target for Journey Medical is $10.00, which is 46.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 46.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Journey Medical has an Altman Z-Score of -0.23 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.23 |
| Piotroski F-Score | 2 |